Nicholas Teman
Concepts (380)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiac Surgical Procedures | 44 | 2026 | 611 | 12.970 |
Why?
| | Coronary Artery Bypass | 16 | 2026 | 269 | 7.050 |
Why?
| | Extracorporeal Membrane Oxygenation | 19 | 2026 | 370 | 6.290 |
Why?
| | Thoracic Surgery | 11 | 2025 | 145 | 4.820 |
Why?
| | Postoperative Complications | 37 | 2026 | 3034 | 3.360 |
Why?
| | Operating Rooms | 7 | 2026 | 145 | 3.260 |
Why?
| | Failure to Rescue, Health Care | 4 | 2026 | 8 | 2.870 |
Why?
| | Surgeons | 10 | 2025 | 351 | 2.420 |
Why?
| | Coronary Artery Disease | 8 | 2025 | 751 | 2.380 |
Why?
| | Intensive Care Units | 8 | 2024 | 925 | 2.310 |
Why?
| | Retrospective Studies | 72 | 2026 | 17438 | 2.080 |
Why?
| | Pulmonary Embolism | 6 | 2024 | 246 | 2.060 |
Why?
| | Heart-Assist Devices | 8 | 2024 | 572 | 1.950 |
Why?
| | Airway Extubation | 4 | 2025 | 60 | 1.820 |
Why?
| | Heart Transplantation | 9 | 2025 | 682 | 1.680 |
Why?
| | Heart Valve Prosthesis Implantation | 8 | 2022 | 197 | 1.630 |
Why?
| | Heart Arrest | 5 | 2024 | 411 | 1.590 |
Why?
| | Treatment Outcome | 39 | 2026 | 11821 | 1.510 |
Why?
| | Purinergic P2Y Receptor Antagonists | 2 | 2025 | 71 | 1.470 |
Why?
| | Propensity Score | 6 | 2025 | 376 | 1.460 |
Why?
| | Cardiopulmonary Bypass | 6 | 2026 | 217 | 1.440 |
Why?
| | Tricuspid Valve Insufficiency | 5 | 2020 | 23 | 1.380 |
Why?
| | Elective Surgical Procedures | 2 | 2024 | 216 | 1.380 |
Why?
| | Length of Stay | 9 | 2026 | 1358 | 1.320 |
Why?
| | Humans | 121 | 2026 | 146342 | 1.300 |
Why?
| | Sternotomy | 4 | 2022 | 25 | 1.290 |
Why?
| | Percutaneous Coronary Intervention | 4 | 2025 | 550 | 1.260 |
Why?
| | Aged | 44 | 2026 | 26432 | 1.160 |
Why?
| | Biomedical Research | 4 | 2025 | 729 | 1.140 |
Why?
| | Middle Aged | 51 | 2026 | 36619 | 1.130 |
Why?
| | Time Factors | 18 | 2026 | 7109 | 1.040 |
Why?
| | Hospital Costs | 5 | 2026 | 131 | 1.030 |
Why?
| | Internship and Residency | 8 | 2026 | 1281 | 1.030 |
Why?
| | Shock, Cardiogenic | 4 | 2024 | 65 | 1.030 |
Why?
| | Hospital Mortality | 11 | 2026 | 1051 | 1.030 |
Why?
| | Risk Factors | 25 | 2026 | 10921 | 1.020 |
Why?
| | Male | 67 | 2026 | 73396 | 0.990 |
Why?
| | Heparin | 3 | 2023 | 247 | 0.970 |
Why?
| | Registries | 9 | 2026 | 2400 | 0.950 |
Why?
| | Receptors, Purinergic P2Y12 | 1 | 2025 | 6 | 0.930 |
Why?
| | Blood Transfusion | 3 | 2025 | 394 | 0.920 |
Why?
| | Patient Isolation | 1 | 2025 | 20 | 0.900 |
Why?
| | Heart Failure | 6 | 2022 | 2329 | 0.900 |
Why?
| | Mitral Valve Insufficiency | 2 | 2018 | 69 | 0.900 |
Why?
| | Female | 62 | 2026 | 79499 | 0.870 |
Why?
| | Catheters | 2 | 2016 | 73 | 0.860 |
Why?
| | Clinical Competence | 6 | 2021 | 1272 | 0.860 |
Why?
| | Non-ST Elevated Myocardial Infarction | 1 | 2025 | 27 | 0.860 |
Why?
| | Myocardial Infarction | 3 | 2024 | 1215 | 0.850 |
Why?
| | Postoperative Hemorrhage | 1 | 2025 | 106 | 0.850 |
Why?
| | Health Care Costs | 3 | 2025 | 423 | 0.840 |
Why?
| | Advanced Cardiac Life Support | 1 | 2024 | 28 | 0.840 |
Why?
| | Education, Medical, Graduate | 3 | 2019 | 568 | 0.830 |
Why?
| | Databases, Factual | 8 | 2024 | 1493 | 0.800 |
Why?
| | Atrial Appendage | 1 | 2024 | 36 | 0.800 |
Why?
| | Delirium | 2 | 2024 | 107 | 0.790 |
Why?
| | Lung Transplantation | 4 | 2025 | 326 | 0.770 |
Why?
| | Certification | 1 | 2024 | 118 | 0.760 |
Why?
| | National Institutes of Health (U.S.) | 2 | 2020 | 147 | 0.730 |
Why?
| | Prosthesis Design | 5 | 2022 | 358 | 0.730 |
Why?
| | Time-to-Treatment | 1 | 2025 | 257 | 0.720 |
Why?
| | Endovascular Procedures | 2 | 2020 | 390 | 0.720 |
Why?
| | Ventricular Dysfunction, Right | 2 | 2022 | 248 | 0.710 |
Why?
| | Atrial Fibrillation | 3 | 2026 | 560 | 0.710 |
Why?
| | Fellowships and Scholarships | 2 | 2026 | 355 | 0.710 |
Why?
| | Thrombosis | 2 | 2023 | 398 | 0.710 |
Why?
| | Sternum | 3 | 2023 | 26 | 0.700 |
Why?
| | Heart Valve Prosthesis | 3 | 2022 | 127 | 0.700 |
Why?
| | Subclavian Vein | 1 | 2021 | 15 | 0.700 |
Why?
| | Risk Assessment | 14 | 2025 | 3712 | 0.690 |
Why?
| | Device Removal | 2 | 2020 | 149 | 0.690 |
Why?
| | Aortic Valve | 5 | 2022 | 360 | 0.690 |
Why?
| | Critical Care | 4 | 2023 | 706 | 0.680 |
Why?
| | Venous Thromboembolism | 1 | 2025 | 332 | 0.660 |
Why?
| | Cost-Benefit Analysis | 3 | 2022 | 640 | 0.650 |
Why?
| | Ventricular Dysfunction | 1 | 2020 | 16 | 0.640 |
Why?
| | Thrombectomy | 2 | 2022 | 79 | 0.640 |
Why?
| | Endocarditis, Bacterial | 1 | 2020 | 46 | 0.630 |
Why?
| | Virginia | 6 | 2023 | 57 | 0.630 |
Why?
| | Ventricular Outflow Obstruction | 1 | 2020 | 38 | 0.620 |
Why?
| | Endocarditis | 1 | 2020 | 40 | 0.620 |
Why?
| | Aortic Valve Stenosis | 5 | 2022 | 255 | 0.620 |
Why?
| | Financing, Organized | 1 | 2020 | 36 | 0.620 |
Why?
| | Catheterization, Central Venous | 1 | 2021 | 121 | 0.610 |
Why?
| | Faculty, Medical | 3 | 2025 | 309 | 0.600 |
Why?
| | Education, Medical | 1 | 2023 | 274 | 0.600 |
Why?
| | Costs and Cost Analysis | 1 | 2020 | 217 | 0.600 |
Why?
| | Organizational Policy | 1 | 2020 | 76 | 0.590 |
Why?
| | Respiratory Insufficiency | 2 | 2020 | 330 | 0.590 |
Why?
| | Thrombocytopenia | 1 | 2021 | 206 | 0.580 |
Why?
| | Tissue Donors | 4 | 2026 | 425 | 0.580 |
Why?
| | Recovery of Function | 1 | 2023 | 725 | 0.580 |
Why?
| | Electronic Mail | 1 | 2019 | 63 | 0.570 |
Why?
| | Negative-Pressure Wound Therapy | 1 | 2019 | 29 | 0.570 |
Why?
| | Hemorrhage | 2 | 2024 | 825 | 0.570 |
Why?
| | Rats, Sprague-Dawley | 1 | 2024 | 2537 | 0.570 |
Why?
| | Hippocampus | 1 | 2024 | 989 | 0.560 |
Why?
| | Tracheostomy | 1 | 2020 | 136 | 0.550 |
Why?
| | Reoperation | 5 | 2025 | 645 | 0.550 |
Why?
| | Machine Learning | 1 | 2024 | 594 | 0.550 |
Why?
| | Students, Medical | 1 | 2023 | 383 | 0.530 |
Why?
| | Patient Transfer | 3 | 2019 | 224 | 0.520 |
Why?
| | Shock, Septic | 1 | 2020 | 230 | 0.520 |
Why?
| | Adult | 27 | 2025 | 41087 | 0.510 |
Why?
| | Survival Rate | 9 | 2024 | 2092 | 0.510 |
Why?
| | General Surgery | 3 | 2015 | 217 | 0.510 |
Why?
| | Quality Improvement | 1 | 2026 | 1354 | 0.500 |
Why?
| | Surgical Wound Infection | 2 | 2023 | 349 | 0.480 |
Why?
| | Aspirin | 1 | 2020 | 405 | 0.480 |
Why?
| | Clinical Decision-Making | 1 | 2019 | 365 | 0.470 |
Why?
| | Educational Measurement | 2 | 2019 | 331 | 0.470 |
Why?
| | Platelet Aggregation Inhibitors | 1 | 2020 | 499 | 0.450 |
Why?
| | Stroke | 2 | 2026 | 1287 | 0.450 |
Why?
| | Patient Reported Outcome Measures | 1 | 2019 | 516 | 0.430 |
Why?
| | Extracorporeal Circulation | 1 | 2014 | 15 | 0.420 |
Why?
| | Perfusion | 3 | 2025 | 255 | 0.420 |
Why?
| | Transportation of Patients | 1 | 2015 | 62 | 0.410 |
Why?
| | Factor Analysis, Statistical | 1 | 2015 | 298 | 0.410 |
Why?
| | Pulsatile Flow | 1 | 2014 | 62 | 0.410 |
Why?
| | Catheterization | 3 | 2024 | 179 | 0.400 |
Why?
| | Sepsis | 1 | 2020 | 669 | 0.390 |
Why?
| | Hemodynamics | 3 | 2022 | 1114 | 0.380 |
Why?
| | Jugular Veins | 1 | 2013 | 41 | 0.380 |
Why?
| | Specialties, Surgical | 1 | 2014 | 88 | 0.380 |
Why?
| | Education, Medical, Continuing | 1 | 2014 | 130 | 0.380 |
Why?
| | Biomarkers | 1 | 2024 | 4340 | 0.380 |
Why?
| | Vasodilator Agents | 1 | 2015 | 326 | 0.380 |
Why?
| | Tertiary Care Centers | 1 | 2014 | 196 | 0.380 |
Why?
| | Aortic Aneurysm | 1 | 2013 | 69 | 0.370 |
Why?
| | Internationality | 1 | 2013 | 156 | 0.370 |
Why?
| | Anticoagulants | 4 | 2023 | 746 | 0.370 |
Why?
| | Myocardial Ischemia | 1 | 2014 | 286 | 0.360 |
Why?
| | Tissue and Organ Procurement | 2 | 2026 | 305 | 0.350 |
Why?
| | United States | 13 | 2026 | 16136 | 0.340 |
Why?
| | Aorta, Thoracic | 1 | 2014 | 284 | 0.340 |
Why?
| | Decision Making | 1 | 2019 | 993 | 0.330 |
Why?
| | Thromboembolism | 1 | 2012 | 129 | 0.330 |
Why?
| | Esophagectomy | 1 | 2012 | 136 | 0.330 |
Why?
| | Acute Disease | 5 | 2024 | 1038 | 0.330 |
Why?
| | Nitric Oxide | 1 | 2015 | 883 | 0.310 |
Why?
| | Patient Positioning | 2 | 2021 | 73 | 0.310 |
Why?
| | Sarcopenia | 2 | 2024 | 100 | 0.300 |
Why?
| | Oxygen | 1 | 2015 | 997 | 0.300 |
Why?
| | Preoperative Care | 1 | 2012 | 396 | 0.290 |
Why?
| | Cardiologists | 2 | 2019 | 45 | 0.290 |
Why?
| | Odds Ratio | 2 | 2023 | 1077 | 0.280 |
Why?
| | Cardiopulmonary Resuscitation | 2 | 2024 | 334 | 0.270 |
Why?
| | Transcatheter Aortic Valve Replacement | 2 | 2022 | 153 | 0.270 |
Why?
| | Esophageal Neoplasms | 1 | 2012 | 351 | 0.270 |
Why?
| | Preoperative Period | 3 | 2019 | 157 | 0.260 |
Why?
| | Frailty | 2 | 2024 | 208 | 0.260 |
Why?
| | Severity of Illness Index | 6 | 2020 | 2921 | 0.260 |
Why?
| | Hypoxia | 1 | 2015 | 1211 | 0.250 |
Why?
| | Survival Analysis | 4 | 2019 | 1378 | 0.250 |
Why?
| | Bioprosthesis | 3 | 2022 | 39 | 0.240 |
Why?
| | Academic Medical Centers | 2 | 2020 | 561 | 0.240 |
Why?
| | Partial Thromboplastin Time | 2 | 2023 | 53 | 0.230 |
Why?
| | Acute Kidney Injury | 2 | 2025 | 866 | 0.230 |
Why?
| | Minimally Invasive Surgical Procedures | 3 | 2024 | 196 | 0.230 |
Why?
| | Incidence | 5 | 2025 | 2936 | 0.220 |
Why?
| | Brain Death | 1 | 2026 | 59 | 0.220 |
Why?
| | Physicians | 1 | 2014 | 955 | 0.220 |
Why?
| | Mitral Valve | 3 | 2024 | 96 | 0.220 |
Why?
| | Patient Selection | 2 | 2019 | 728 | 0.220 |
Why?
| | Michigan | 3 | 2017 | 203 | 0.220 |
Why?
| | Intracranial Pressure | 1 | 2025 | 64 | 0.220 |
Why?
| | Follow-Up Studies | 6 | 2026 | 5439 | 0.210 |
Why?
| | Efficiency, Organizational | 1 | 2026 | 144 | 0.210 |
Why?
| | Radial Artery | 1 | 2025 | 74 | 0.210 |
Why?
| | Prognosis | 7 | 2026 | 4351 | 0.210 |
Why?
| | Ligation | 1 | 2024 | 88 | 0.210 |
Why?
| | Heart Septal Defects, Ventricular | 1 | 2024 | 44 | 0.210 |
Why?
| | Blood Pressure | 2 | 2025 | 1765 | 0.200 |
Why?
| | Phlebotomy | 1 | 2024 | 21 | 0.200 |
Why?
| | Social Class | 2 | 2023 | 260 | 0.200 |
Why?
| | Systemic Inflammatory Response Syndrome | 1 | 2024 | 97 | 0.200 |
Why?
| | Logistic Models | 4 | 2023 | 2126 | 0.200 |
Why?
| | Random Allocation | 1 | 2024 | 366 | 0.200 |
Why?
| | Factor IX | 1 | 2023 | 49 | 0.200 |
Why?
| | Publishing | 1 | 2025 | 117 | 0.200 |
Why?
| | Factor VIIa | 1 | 2023 | 43 | 0.200 |
Why?
| | Transplant Recipients | 1 | 2025 | 177 | 0.190 |
Why?
| | Lung Injury | 2 | 2017 | 263 | 0.190 |
Why?
| | Waiting Lists | 1 | 2025 | 251 | 0.190 |
Why?
| | Iatrogenic Disease | 1 | 2024 | 74 | 0.190 |
Why?
| | Hospitals, Low-Volume | 1 | 2023 | 26 | 0.190 |
Why?
| | Coronary Angiography | 1 | 2025 | 325 | 0.190 |
Why?
| | Hospitals, High-Volume | 1 | 2023 | 51 | 0.190 |
Why?
| | Renal Replacement Therapy | 1 | 2023 | 102 | 0.190 |
Why?
| | Blood Coagulation Factors | 1 | 2023 | 71 | 0.190 |
Why?
| | Cerebrovascular Circulation | 1 | 2025 | 293 | 0.190 |
Why?
| | Organ Transplantation | 1 | 2026 | 244 | 0.180 |
Why?
| | Morbidity | 2 | 2020 | 319 | 0.180 |
Why?
| | Disease Models, Animal | 4 | 2024 | 4580 | 0.180 |
Why?
| | Cost Savings | 1 | 2022 | 87 | 0.180 |
Why?
| | Urban Population | 1 | 2025 | 497 | 0.180 |
Why?
| | Acute Lung Injury | 2 | 2018 | 312 | 0.180 |
Why?
| | Mentors | 2 | 2021 | 217 | 0.180 |
Why?
| | Catheter Ablation | 1 | 2026 | 355 | 0.180 |
Why?
| | Pacemaker, Artificial | 2 | 2020 | 127 | 0.180 |
Why?
| | Surgical Drapes | 1 | 2021 | 2 | 0.180 |
Why?
| | Medical Illustration | 1 | 2021 | 10 | 0.180 |
Why?
| | Contrast Media | 1 | 2025 | 493 | 0.170 |
Why?
| | Tricuspid Valve | 2 | 2022 | 42 | 0.170 |
Why?
| | Schools, Medical | 1 | 2023 | 158 | 0.170 |
Why?
| | Punctures | 1 | 2021 | 40 | 0.170 |
Why?
| | Suction | 1 | 2021 | 31 | 0.170 |
Why?
| | Bandages | 1 | 2021 | 38 | 0.170 |
Why?
| | Renal Insufficiency | 1 | 2023 | 173 | 0.170 |
Why?
| | Kaplan-Meier Estimate | 4 | 2019 | 970 | 0.170 |
Why?
| | Work-Life Balance | 1 | 2021 | 22 | 0.170 |
Why?
| | Interleukin-8 | 1 | 2022 | 268 | 0.170 |
Why?
| | Practice Guidelines as Topic | 2 | 2020 | 1591 | 0.170 |
Why?
| | Dilatation | 1 | 2021 | 73 | 0.170 |
Why?
| | United Kingdom | 1 | 2022 | 377 | 0.160 |
Why?
| | Socioeconomic Factors | 2 | 2022 | 1327 | 0.160 |
Why?
| | Antineoplastic Agents | 1 | 2012 | 2219 | 0.160 |
Why?
| | Heart Block | 1 | 2020 | 41 | 0.160 |
Why?
| | Blood Coagulation | 1 | 2022 | 267 | 0.160 |
Why?
| | Cohort Studies | 6 | 2020 | 6077 | 0.160 |
Why?
| | Checklist | 1 | 2021 | 105 | 0.160 |
Why?
| | Vagus Nerve Injuries | 1 | 2020 | 2 | 0.160 |
Why?
| | Rural Population | 1 | 2025 | 677 | 0.160 |
Why?
| | Recombinant Proteins | 1 | 2023 | 1361 | 0.160 |
Why?
| | Coronary Artery Bypass, Off-Pump | 1 | 2020 | 16 | 0.160 |
Why?
| | Disinfection | 1 | 2021 | 131 | 0.150 |
Why?
| | Donor Selection | 1 | 2020 | 66 | 0.150 |
Why?
| | Informed Consent | 1 | 2021 | 195 | 0.150 |
Why?
| | Swine | 3 | 2022 | 821 | 0.150 |
Why?
| | Vagus Nerve | 1 | 2020 | 92 | 0.150 |
Why?
| | Societies, Medical | 1 | 2024 | 907 | 0.150 |
Why?
| | Renal Dialysis | 1 | 2023 | 461 | 0.150 |
Why?
| | Cardiac Catheterization | 1 | 2023 | 571 | 0.150 |
Why?
| | Adenosine A2 Receptor Agonists | 1 | 2019 | 24 | 0.150 |
Why?
| | Research Support as Topic | 1 | 2019 | 83 | 0.140 |
Why?
| | Learning Curve | 1 | 2019 | 71 | 0.140 |
Why?
| | Teaching | 1 | 2021 | 244 | 0.140 |
Why?
| | Echocardiography, Transesophageal | 1 | 2019 | 132 | 0.140 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2025 | 1763 | 0.140 |
Why?
| | Healthcare Disparities | 1 | 2025 | 733 | 0.140 |
Why?
| | Lipopolysaccharides | 1 | 2022 | 861 | 0.140 |
Why?
| | Biological Products | 1 | 2022 | 258 | 0.140 |
Why?
| | Prosthesis Fitting | 1 | 2018 | 11 | 0.140 |
Why?
| | Warm Ischemia | 1 | 2018 | 35 | 0.130 |
Why?
| | Cardiac Valve Annuloplasty | 1 | 2017 | 3 | 0.130 |
Why?
| | Psoas Muscles | 1 | 2018 | 24 | 0.130 |
Why?
| | Gastrointestinal Diseases | 1 | 2020 | 220 | 0.130 |
Why?
| | Heart Failure, Systolic | 1 | 2018 | 26 | 0.130 |
Why?
| | Protective Agents | 1 | 2018 | 43 | 0.130 |
Why?
| | Sphingosine | 1 | 2018 | 46 | 0.130 |
Why?
| | Coronary Disease | 1 | 2020 | 380 | 0.130 |
Why?
| | Cardiac Pacing, Artificial | 1 | 2018 | 83 | 0.130 |
Why?
| | Aortic Aneurysm, Thoracic | 1 | 2019 | 135 | 0.130 |
Why?
| | Lysophospholipids | 1 | 2018 | 80 | 0.130 |
Why?
| | Leadership | 1 | 2021 | 414 | 0.130 |
Why?
| | Patient Readmission | 1 | 2023 | 778 | 0.120 |
Why?
| | Health Services Accessibility | 1 | 2025 | 1107 | 0.120 |
Why?
| | Drug Therapy, Combination | 1 | 2020 | 1036 | 0.120 |
Why?
| | Skin | 1 | 2021 | 701 | 0.120 |
Why?
| | Workload | 2 | 2019 | 170 | 0.120 |
Why?
| | Reperfusion Injury | 1 | 2019 | 300 | 0.120 |
Why?
| | Stents | 1 | 2020 | 554 | 0.120 |
Why?
| | Kidney Transplantation | 1 | 2023 | 735 | 0.120 |
Why?
| | Rats | 1 | 2024 | 5586 | 0.120 |
Why?
| | Kidney | 1 | 2023 | 1498 | 0.110 |
Why?
| | Intubation, Intratracheal | 1 | 2018 | 330 | 0.110 |
Why?
| | Guideline Adherence | 1 | 2020 | 594 | 0.110 |
Why?
| | Partial Pressure | 1 | 2015 | 30 | 0.110 |
Why?
| | Animals | 6 | 2024 | 38107 | 0.110 |
Why?
| | Equipment Design | 1 | 2016 | 520 | 0.110 |
Why?
| | Blood Gas Analysis | 1 | 2015 | 80 | 0.110 |
Why?
| | Hospitals | 1 | 2020 | 738 | 0.110 |
Why?
| | Formative Feedback | 1 | 2015 | 38 | 0.110 |
Why?
| | Comorbidity | 1 | 2020 | 1665 | 0.110 |
Why?
| | Hepatectomy | 1 | 2016 | 256 | 0.100 |
Why?
| | Staff Development | 1 | 2015 | 64 | 0.100 |
Why?
| | Patient Care Team | 1 | 2020 | 701 | 0.100 |
Why?
| | Myxoma | 1 | 2014 | 11 | 0.100 |
Why?
| | Pandemics | 1 | 2023 | 1707 | 0.100 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 1 | 2023 | 1195 | 0.100 |
Why?
| | Practice Patterns, Physicians' | 2 | 2020 | 1408 | 0.100 |
Why?
| | Heart Neoplasms | 1 | 2014 | 56 | 0.100 |
Why?
| | Administration, Inhalation | 1 | 2015 | 567 | 0.100 |
Why?
| | Analgesics, Opioid | 1 | 2022 | 1221 | 0.100 |
Why?
| | Echocardiography, Doppler | 1 | 2014 | 117 | 0.100 |
Why?
| | Inflammation | 1 | 2024 | 2919 | 0.090 |
Why?
| | Travel | 2 | 2025 | 134 | 0.090 |
Why?
| | Chemoradiotherapy, Adjuvant | 1 | 2012 | 44 | 0.090 |
Why?
| | Hemolysis | 1 | 2014 | 242 | 0.090 |
Why?
| | Primary Prevention | 1 | 2014 | 222 | 0.090 |
Why?
| | Body Mass Index | 1 | 2020 | 2458 | 0.090 |
Why?
| | Sheep | 1 | 2014 | 870 | 0.080 |
Why?
| | Data Collection | 1 | 2014 | 650 | 0.080 |
Why?
| | Aorta | 1 | 2014 | 440 | 0.080 |
Why?
| | Mental Disorders | 1 | 2020 | 1148 | 0.080 |
Why?
| | Surgical Procedures, Operative | 1 | 2014 | 307 | 0.080 |
Why?
| | Recurrence | 1 | 2014 | 1133 | 0.080 |
Why?
| | Thoracotomy | 2 | 2022 | 87 | 0.080 |
Why?
| | Respiration, Artificial | 1 | 2015 | 711 | 0.080 |
Why?
| | Anti-Bacterial Agents | 1 | 2020 | 1942 | 0.070 |
Why?
| | Lung Neoplasms | 1 | 2023 | 2675 | 0.070 |
Why?
| | Echocardiography | 3 | 2018 | 645 | 0.070 |
Why?
| | Neoadjuvant Therapy | 1 | 2012 | 475 | 0.070 |
Why?
| | Diagnosis, Differential | 1 | 2013 | 1503 | 0.070 |
Why?
| | Heart Ventricles | 1 | 2014 | 762 | 0.070 |
Why?
| | Lung | 2 | 2022 | 4122 | 0.070 |
Why?
| | Myocardium | 1 | 2014 | 948 | 0.070 |
Why?
| | Aged, 80 and over | 4 | 2026 | 8391 | 0.070 |
Why?
| | Algorithms | 1 | 2015 | 1849 | 0.060 |
Why?
| | Obesity | 1 | 2020 | 3131 | 0.060 |
Why?
| | Multivariate Analysis | 2 | 2021 | 1543 | 0.060 |
Why?
| | Tomography, X-Ray Computed | 1 | 2016 | 2786 | 0.060 |
Why?
| | Operative Time | 1 | 2026 | 195 | 0.050 |
Why?
| | Organ Preservation | 1 | 2026 | 123 | 0.050 |
Why?
| | Publications | 1 | 2025 | 48 | 0.050 |
Why?
| | Efficiency | 1 | 2025 | 102 | 0.050 |
Why?
| | Mediastinum | 1 | 2023 | 23 | 0.050 |
Why?
| | Unemployment | 1 | 2023 | 43 | 0.050 |
Why?
| | Spike Glycoprotein, Coronavirus | 1 | 2023 | 129 | 0.050 |
Why?
| | Ventilators, Mechanical | 1 | 2022 | 70 | 0.040 |
Why?
| | Tidal Volume | 1 | 2022 | 108 | 0.040 |
Why?
| | Lymph Node Excision | 1 | 2023 | 174 | 0.040 |
Why?
| | Cluster Analysis | 1 | 2023 | 496 | 0.040 |
Why?
| | Surveys and Questionnaires | 1 | 2014 | 6073 | 0.040 |
Why?
| | Antibodies | 1 | 2023 | 400 | 0.040 |
Why?
| | Employment | 1 | 2023 | 180 | 0.040 |
Why?
| | Prospective Studies | 1 | 2013 | 8123 | 0.040 |
Why?
| | Predictive Value of Tests | 2 | 2018 | 2113 | 0.040 |
Why?
| | Quality-Adjusted Life Years | 1 | 2020 | 122 | 0.040 |
Why?
| | Quality Indicators, Health Care | 1 | 2023 | 343 | 0.040 |
Why?
| | Lymph Nodes | 1 | 2023 | 511 | 0.040 |
Why?
| | Toll-Like Receptor 4 | 1 | 2022 | 277 | 0.040 |
Why?
| | Ligands | 1 | 2022 | 678 | 0.040 |
Why?
| | Erythrocyte Transfusion | 1 | 2022 | 226 | 0.040 |
Why?
| | Acetaminophen | 1 | 2022 | 268 | 0.040 |
Why?
| | Heart | 1 | 2023 | 626 | 0.040 |
Why?
| | Neoplasm Staging | 1 | 2023 | 1488 | 0.040 |
Why?
| | North Carolina | 1 | 2018 | 127 | 0.030 |
Why?
| | Pain Management | 1 | 2022 | 421 | 0.030 |
Why?
| | Lung Abscess | 1 | 2018 | 6 | 0.030 |
Why?
| | Decompressive Craniectomy | 1 | 2018 | 9 | 0.030 |
Why?
| | Interleukin-6 | 1 | 2022 | 784 | 0.030 |
Why?
| | Polytetrafluoroethylene | 1 | 2018 | 24 | 0.030 |
Why?
| | Empyema, Pleural | 1 | 2018 | 13 | 0.030 |
Why?
| | Organ Preservation Solutions | 1 | 2018 | 47 | 0.030 |
Why?
| | Graft Survival | 1 | 2020 | 523 | 0.030 |
Why?
| | Age Factors | 1 | 2025 | 3347 | 0.030 |
Why?
| | Educational Status | 1 | 2019 | 466 | 0.030 |
Why?
| | Death | 1 | 2018 | 129 | 0.030 |
Why?
| | Observer Variation | 1 | 2018 | 356 | 0.030 |
Why?
| | Cerebral Hemorrhage | 1 | 2018 | 125 | 0.030 |
Why?
| | Suture Techniques | 1 | 2018 | 138 | 0.030 |
Why?
| | Organ Size | 1 | 2018 | 465 | 0.030 |
Why?
| | Myocarditis | 1 | 2018 | 103 | 0.030 |
Why?
| | Administration, Oral | 1 | 2019 | 872 | 0.030 |
Why?
| | Endothelial Cells | 1 | 2022 | 876 | 0.030 |
Why?
| | Cause of Death | 1 | 2017 | 456 | 0.030 |
Why?
| | Needs Assessment | 1 | 2018 | 404 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2019 | 2022 | 0.030 |
Why?
| | Stroke Volume | 1 | 2018 | 652 | 0.030 |
Why?
| | Vaccination | 1 | 2023 | 1449 | 0.030 |
Why?
| | Proportional Hazards Models | 1 | 2017 | 1331 | 0.030 |
Why?
| | Prevalence | 1 | 2020 | 2861 | 0.020 |
Why?
| | Longitudinal Studies | 1 | 2020 | 3017 | 0.020 |
Why?
| | Curriculum | 1 | 2019 | 1079 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2020 | 3647 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2016 | 1998 | 0.020 |
Why?
| | Emergency Medical Services | 1 | 2019 | 680 | 0.020 |
Why?
| | Quality of Life | 1 | 2023 | 3200 | 0.020 |
Why?
| | Child | 2 | 2022 | 22693 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2016 | 3416 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2018 | 6034 | 0.020 |
Why?
| | Hospitalization | 1 | 2016 | 2475 | 0.010 |
Why?
| | Infant, Newborn | 1 | 2014 | 6460 | 0.010 |
Why?
| | Magnetic Resonance Imaging | 1 | 2014 | 3926 | 0.010 |
Why?
| | Mice | 1 | 2018 | 18297 | 0.010 |
Why?
| | Infant | 1 | 2014 | 10114 | 0.010 |
Why?
| | Child, Preschool | 1 | 2014 | 11913 | 0.010 |
Why?
| | Young Adult | 1 | 2014 | 14330 | 0.010 |
Why?
| | Adolescent | 1 | 2014 | 22557 | 0.010 |
Why?
|
|
Teman's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|